Oncology Central

Zika vaccine yields promising results for treating glioblastoma

0
An international team of researchers have successfully deployed a Zika virus vaccine to target and kill human glioblastoma brain cancer stem cells, which had been transplanted into mice.

In the study, published in mBio®, the team demonstrate that a live, attenuated version of the Zika virus could form the basis of a new treatment option for this fatal brain cancer.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.

Share:

Insights

Videos

News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.